+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Diabetic Nephropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Nephropathy Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
From
Injection Pens - Global Strategic Business Report - Product Thumbnail Image

Injection Pens - Global Strategic Business Report

  • Report
  • November 2024
  • 233 Pages
  • Global
From
Renal cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Renal cell carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • November 2024
  • 293 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
From
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
KEYTRUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEYTRUDA Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Loading Indicator